Edward Unkart

AlterG, Inc. develops weight reduction athletic equipment. Its products are used by major medical centers, leading physical therapy clinics and professional, collegiate, and individual sports and fitness programs. The firm?s products include anti gravity treadmill, bionic leg and accessories. AlterG was founded by Michael Brenton Looney, Fritz Moore, Edward Liou and Sean Whalen in 2005 and is headquartered in Fremont, CA.

KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.

Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA.

Xtent, Inc. is a medical devices manufacturing company. The company develops drug-eluting stent systems for the treatment of multi-vessel, multi-lesion coronary and peripheral vascular diseases. Xtent was founded in 2002 and is headquartered in Menlo Park, CA.

VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA.

SurgRx, Inc. develops tissue sealing and cutting technology. The company's products include EnSeal, TRIO, PowerTip, RF-60, and universal RF Generator. It also develops vessel fusion system used in electrosurgical devices. The company was founded in 2001 and is headquartered in Redwood City, CA.

CYTYC Surgical Products was founded to design, develop, manufacture and market innovative therapeutic devices that improve the quality of women's healthcare in a cost- effective manner. Its initial product, the Novasure Endometrial Ablation System, is used to treat women who suffer from excessive menstrual bleeding.